{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "HKD", "exchange": "HKG", "shortName": "JACOBIO-B", "longName": "Jacobio Pharmaceuticals Group Co., Ltd.", "messageBoardId": "finmb_568186910", "market": "hk_market", "marketState": "CLOSED", "earningsTimestamp": 1679533200, "earningsTimestampStart": 1679533200, "earningsTimestampEnd": 1679533200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.56, "epsForward": -0.5, "epsCurrentYear": -0.39, "priceEpsCurrentYear": -19.179487, "sharesOutstanding": 793561984, "bookValue": 1.662, "fiftyDayAverage": 7.9354, "fiftyDayAverageChange": -0.4554, "fiftyDayAverageChangePercent": -0.05738841, "twoHundredDayAverage": 5.88155, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "gmtOffSetMilliseconds": 28800000, "esgPopulated": false, "regularMarketChangePercent": 1.4925392, "regularMarketPrice": 7.48, "regularMarketChange": 0.11000013, "regularMarketTime": 1683878916, "regularMarketDayHigh": 7.53, "regularMarketDayRange": "7.23 - 7.53", "regularMarketDayLow": 7.23, "regularMarketVolume": 2538300, "regularMarketPreviousClose": 7.37, "bid": 7.46, "ask": 7.48, "fullExchangeName": "HKSE", "financialCurrency": "CNY", "regularMarketOpen": 7.27, "averageDailyVolume3Month": 5448304, "averageDailyVolume10Day": 2057100, "fiftyTwoWeekLowChange": 4.1800003, "fiftyTwoWeekLowChangePercent": 1.2666668, "fiftyTwoWeekRange": "3.3 - 10.48", "fiftyTwoWeekHighChange": -2.9999995, "fiftyTwoWeekHighChangePercent": -0.2862595, "fiftyTwoWeekLow": 3.3, "fiftyTwoWeekHigh": 10.48, "twoHundredDayAverageChange": 1.5984502, "twoHundredDayAverageChangePercent": 0.27177364, "marketCap": 5935843840, "forwardPE": -14.96, "priceToBook": 4.500602, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "ipoExpectedDate": "2020-12-14", "averageAnalystRating": "1.7 - Buy", "firstTradeDateMilliseconds": 1608514200000, "priceHint": 3, "symbol": "1167.HK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building F2", "address2": "No. 88 Kechuang 6th Street Beijing Economic-Technological Dev. Zn.", "city": "Beijing", "zip": "101111", "country": "China", "phone": "86 10 5631 5466", "fax": "86 10 5631 5314", "website": "https://www.jacobiopharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Jacobio Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors comprising JAB-3312 and JAB-3068 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein. It is also develops JAB-BX102, a humanized inhibitory antibody against human CD73 for the treatment of PD-1 resistant cancer; JAB-6343, an inhibitor that targets fibroblast growth factor receptor 4 for advanced hepatocellular carcinoma with FGF19 overexpression; JAB-2485, an aurora A kinase inhibitor for solid tumors; JAB-24114, a tumor metabolic pathway for the treatment of solid tumors; and JAB-BX300, a molecule antibody targeting RAS pathway to treat pancreatic and other solid tumors with KRAS mutations. The company has a strategic collaboration with AbbVie Ireland Unlimited Company to develop and commercialize SHP2 inhibitors. Jacobio Pharmaceuticals Co., Ltd. was incorporated in 2015 and is headquartered in Beijing, China.", "fullTimeEmployees": 303, "companyOfficers": [{"maxAge": 1, "name": "Dr. Yinxiang  Wang", "age": 57, "title": "Exec. Chairman & CEO", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Xiaojie  Wang", "age": 58, "title": "Exec. Director & Pres of Admin.", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Yunyan  Hu", "age": 60, "title": "Exec. VP & Exec. Director", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Andrea  Wang-Gillam M.D., Ph.D.", "age": 51, "title": "Exec. VP & Chief Medical Officer", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Qing  Xue", "age": 33, "title": "Joint Company Sec.", "yearBorn": 1989, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ming Fai  Chung CPA", "age": 43, "title": "Joint Company Sec.", "yearBorn": 1979, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}